Abstract
Acne vulgaris is a chronic, inflammatory disease of the sebaceous follicle characterized by increased sebum secretion and formation of follicle-associated closed and open comedones, papules, pustules and nodules; pseudocysts and several types of scars are sequelae of the primary lesions [1]. Acne is a most common skin disease seen worldwide. However, its incidence and clinical presentation differ in various geographic areas and ethnicities. The disease is less commonly seen in populations with dark skin living in developing countries in Africa. In contrast, acne is on the top list of dermatoses seen in African Americans in the USA [2, 3], indicating that environmental factors may play a prominent role in the pathogenesis of the disease. Acne vulgaris in dark skin is frequently either mild comedonal or nodular, in contrast to the classical presentation of acne papulopustulosa in fair skin (Table 18.1). In addition, facial acneiform dermatoses are frequently seen in patients with dark skin in Africa and India, more often than acne vulgaris itself. On the other hand, it seems that metabolic abnormalities associated with acne are overrepresented in India. Overall, the disease has a significant impact on the quality of life of young individuals worldwide and requires medical assistance and continuing support.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zouboulis CC. Acne as a chronic systemic disease. Clin Dermatol. 2014;32:389–96.
Alexis AF. Acne vulgaris in skin of color: understanding nuances and optimizing treatment outcomes. J Drugs Dermatol. 2014;13:s61–5.
Davis SA, Narahari S, Feldman SR, et al. Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol. 2012;11:466–73.
Zouboulis CC. Acne vulgaris. Hautarzt. 2014;65:733–50.
Okoro OE, Sani H. Pattern of skin diseases at the dermatology clinic of Jos University Teaching Hospital, Jos Plateau state Nigeria. Jos J Med. 2014;8:15–21.
Ogunbiyi AO, Omigbodun Y, Owoaje E. Prevalence of skin disorders in school children in South-West Nigeria. Int J Adolesc Med Health. 2009;21:235–41.
Yahaya H. Acne vulgaris in Nigerian adolescents—prevalence, severity, beliefs, perceptions, and practices. Int J Dermatol. 2009;48:489–505.
Okoro OE, Ogunbiyi AO, George AO. Prevalence and pattern of acne vulgaris among adolescents in Ibadan, south-west Nigeria. J Egypt Women Dermatol Soc. 2016;13:7–12.
Hartshorne ST. Dermatological disorders in Johannesburg, South Africa. Clin Exp Dermatol. 2003;148:193–4.
Ogunbiyi AO, Daramola OOM, Alese OO. Prevalence of skin diseases in Ibadan Nigeria. Int J Dermatol. 2004;43:31–6.
Henshaw EB, Olasode OA, Ogedegbe EE, et al. Dermatologic conditions in teenage adolescents in Nigeria. Adolesc Health Med Ther. 2014;5:79–87.
Lynn DD, Umari T, Dunnick CA, et al. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther. 2016;7:13–25.
Perkins A, Cheng C, Hillebrand G, et al. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indians and African American women. J Eur Acad Dermatol Venereol. 2011;25:1054–60.
Cordain L, Lindeberg S, Hurtado M, et al. Acne vulgaris: a disease of western civilization. Arch Dermatol. 2002;138:1584–90.
Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004;22:360–6.
Zouboulis CC, Jourdan E, Picardo M. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol. 2014;28:527–32.
Gollnick H, Zouboulis CC. Not all acne is acne vulgaris. Dtsch Arztbl Int. 2014;111:301–12.
Moradi-Tuchayi S, Makrantonaki E, Ganceviciene R, et al. Acne vulgaris. Nature Rev Dis Primers. 2015;1:15029.
Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology. 2003;206:24–8.
Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. 2009;129:2136–41.
Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology. 2001;203:277–9.
Zouboulis CC, Seltmann H, Hiroi N, et al. Corticotropin releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A. 2002;99:7148–53.
Ganceviciene R, Graziene V, Fimmel S, et al. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol. 2009;160:345–52.
Pappas A, Fantasia J, Chen T. Age and ethnic variations in sebaceous lipids. Dermatoendocrinology. 2013;5:319–24.
Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne? Exp Dermatol. 2005;14:143–52.
Zouboulis CC, Schagen S, Alestas T. The sebocyte culture: a model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhoea and acne. Arch Dermatol Res. 2008;300:397–413.
Cappel M, Mauger D, Thibutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol. 2005;141:333–8.
Vora S, Ovhal A, Jerajani H, et al. Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol. 2008;159:990–1.
Kubba R, Bajaj AK, Thappa DM, et al. Acne in India: guidelines for management—IAA consensus document. Ind J Dermatol Venereol Leprol. 2009;75:S1–62.
Silverberg JI, Silverberg NB. Epidemiology and extracutaneous comorbidities of severe acne in adolescence: an U.S. population-based study. Br J Dermatol. 2014;170:1136–42.
Davis EC, Callender VD. A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol. 2010;3:24–38.
Kubba R. Acne in dark skin people. In: Schwartz RA, Micali G, editors. Acne. Gurgaon: Macmillan; 2013. p. 39–50.
Kubba R, Chatrath V. Acne expression and management in Indians. World Clin Dermatol. 2013;1:105–27.
Jacinto-Jamora S, Tamesis J, Katigbak MI. Pityrosporum folliculitis in the Philippines: diagnosis, prevalence and management. J Am Acad Dermatol. 1991;24:693–6.
Youn NH, Cha SH, Park S. Malassezia yeasts in acne vulgaris. Korean J Dermatol. 2002;40:1453–60.
Ju Q, Yiang K, Zouboulis CC, et al. Chloracne: from clinic to research. Dermatol Sin. 2012;30:2–6.
Adler YD, Zouboulis CC, Geilen CC, et al. Eine seltene Variante des SAHA syndroms. Z Hautkr. 2001;76:327–8.
Orfanos CE, Adler YD, Zouboulis CC. The SAHA syndrome. Horm Res. 2000;54:251–8.
Sanke S, Chander R, Jain A, et al. A comparison of the hormone profile of the early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women. JAMA Dermatol. 2016;152:986–91.
Svetlana T, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004;89:2526–34.
Globerman H, Carnieli E. Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans. Int J Obes Relat Metab Disord. 1998;22:349–53.
Dunaif A, Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81:942–7.
Rahman MA, De D, Handa S, et al. Association of insulin-like growth factor (IGF-1) gene polymorphisms with plasma levels of IGF-1 and acne severity. J Am Acad Dermatol. 2016;75:768–73.
Honour JW. 17-Hydroxyprogesterone in children, adolescents and adults. Ann Clin Biochem. 2014;51:424–40.
Plewig G, Kligman AM. Induction of acne by topical steroids. Arch Dermatol Forsch. 1973;247:29–52.
Saraswat A, Lahiri K, Chatterjee M, et al. Topical corticosteroid abuse on the face: a prospective, multicentre study of dermatology outpatients. Ind J Dermatol Venereol Leprol. 2011;77:160–6.
Goh CL, Abad-Casinthan F, Chow SK, et al. Evaluating acne-related post-inflammatory hyperpigmentation is a challenge even amongst experts. J Dermatol. 2014;41:1106–8.
Hayashi N, Miyachi Y, Kawashima M. Prevalence of scars and “mini-scars”, and their impact on quality of life in Japanese patients with acne. J Dermatol. 2015;42:690–6.
Nast A, Dréno B, Bettoli V, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(suppl 1):1–29.
Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46:S98–106.
Sardana K, Gupta T, Kumar B, et al. Cross-sectional pilot study of antibiotic resistance in Propionibacterium acnes strains in Indian acne patients using 16S-RNA polymerase chain reaction: a comparison among treatment modalities including antibiotics, benzoyl peroxide, and isotretinoin. Ind J Dermatol. 2016;61:45–52.
Zouboulis CC, Rabe T. Hormonelle Antiandrogene in der Aknetherapie. J Dtsch Dermatol Ges. 2010;8(suppl 1):S60–74.
Ganceviciene R, Zouboulis C. Isotretinoin for acne vulgaris: state-of-the-art treatment for acne vulgaris. J Dtsch Dermatol Ges. 2010;8(suppl 1):S47–59.
Borghi A, Mantovani L, Minghetti S, et al. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission. J Eur Acad Dermatol Venereol. 2011;25:1094–8.
Dhaked DR, Meena RS, Maheshwari A, et al. A randomized comparative trial of two low-dose isotretinoin regimens in moderate to severe acne vulgaris. Ind Dermatol Online J. 2016;7:378–85.
Walling HW, Messingham M, Myers LM, et al. Improvement of acanthosis nigricans on isotretinoin and metformin. J Drugs Dermatol. 2003;6:677–81.
Fabbrocini G, Izzo R, Faggiano A, et al. Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments. Clin Exp Dermatol. 2016;41:38–42.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Zouboulis, C.C., Okoro, E., Kubba, R. (2018). Acne in Dark Skin. In: Orfanos, C., Zouboulis, C., Assaf, C. (eds) Pigmented Ethnic Skin and Imported Dermatoses. Springer, Cham. https://doi.org/10.1007/978-3-319-69422-1_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-69422-1_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-69421-4
Online ISBN: 978-3-319-69422-1
eBook Packages: MedicineMedicine (R0)